2019-Novel Coronavirus (2019-nCoV) Triplex RT-qPCR Detection Kit CE-IVD; In-Stock, Delivery: 1-2 days
Catalog No : VB-CD302-02
349.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | 2019-Novel Coronavirus (2019-nCoV) Triplex RT-qPCR Detection Kit CE-IVD; In-Stock, Delivery: 1-2 days | ||
---|---|---|---|
Catalog No | VB-CD302-02 | ||
Supplier’s Catalog No | CD302-02 | ||
Supplier | Vazyme | ||
Source antigen | SARS-CoV2 | ||
Reactivity | RdRP and N genes of SASR-CoV2; Internal control: Human RNP gene | ||
Cross reactivity | None | ||
Applications | Quantitative RT-PCR | ||
Molecular weight | N/A |
Storage | Store at -15 to -30°C | ||
---|---|---|---|
Other names | SARS-CoV-2 RT-PCR, nCoV-2 RT-PCR, novel coronavirus 2019, qPCR, quantitative PCR | ||
Grade | Molecular diagnostic grade | ||
Purity | IVD grade | ||
Form | Liquid | ||
Reactivity life | 6 months from production date. | ||
Note | For Professional In Vitro diagnostics. | ||
Description | This product provides triplex-detections in a single tube, including two independent genes of 2019-nCoV and an internal control which targets the human RNAse P (RNP) gene to assess specimen quality. Specifc primers and probes were designed for the detection of conserved region of 2019-nCoV’s ORF1ab gene and N gene, respectively, avoiding nonspecifc interference of SARS2003 and BatSARS-like virus strains. Internal control (RNAse P gene) provides a nucleic acid extraction procedural control and a secondary negative control. Positive control (2019-nCoV-pseudoviruse) provides a nucleic acid extraction and a reverse transcription control to validate the entire procedure and reagent integrity. Limit of Detection: 200 copies/mL. Compatibility: Real-Time PCR instrument with FAM, TEXAS RED/ROX and HEX/VIC channels, such as ABI7500, ABI Q3, ABI Q6, Roche LightCycler480, Bio-Rad CFX96. |
© 2020 Imugex All Rights Reserved